Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6674117 | 7361547 | I | 6674117-5 | 20080901 | 20100326 | 20100407 | EXP | TCI2010A01156 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | 55 | YR | M | N | 20100406 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6674117 | 1013471396 | PS | ACTOS | 1 | ORAL | 15 MG (15 MG, 1 D) PER ORAL; PER ORAL | Y | Y | 21073 | ||
| 6674117 | 1013541425 | C | AMARYL | 1 | |||||||
| 6674117 | 1013541438 | C | DIOVAN | 1 | |||||||
| 6674117 | 1013541440 | C | METFORMIN HYDROCHLORIDE | 1 | |||||||
| 6674117 | 1013541443 | C | LIPITOR | 1 | |||||||
| 6674117 | 1013541444 | C | ASPIRIN | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6674117 | 1013471396 | DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6674117 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6674117 | ABASIA |
| 6674117 | ARTHRALGIA |
| 6674117 | IMPAIRED WORK ABILITY |
| 6674117 | WEIGHT INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6674117 | FGN |
| 6674117 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6674117 | 1013471396 | 20070607 | 20091001 | 2 | YR |
| 6674117 | 1013471396 | 20091201 | 20091201 |